Velagliflozin proline is an oralsodium-glucose cotransporter 2(SGLT2) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar andinsulinconcentrations^[1].

Velagliflozin (1 mg/kg, 口服, 单剂量) proline 增加胆固醇、白蛋白、β -羟基丁酸 (BHB)、非酯化脂肪酸 (NEFA) 和尿葡萄糖排泄，并降低猫的呼吸交换比率^[1]。
Velagliflozin (0.3 mg/kg; 口服; 每天 1 次, 共 18 天) proline 耐受性良好，可通过降低饮食非结构性碳水化合物 (NSC) 的高胰岛素反应来治疗小马的胰岛素失调和预防椎板炎^[2]。

510.58

C₂₈H₃₄N₂O₇

1539295-26-5

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.